Court Suspends Alnylam Patent-Adjustment Suit Pending Outcome of Separate Litigation

Alnylam’s request to stay the suit, which was submitted jointly with the USPTO, asked the court to suspend the case until a ruling is made on an appeal in a separate but similar patent-term suit filed by Wyeth and Elan Pharma against the patent office.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.